Simultaneous monitoring of oxidation, deamidation, isomerization, and glycosylation of monoclonal antibodies by liquid chromatography-mass spectrometry method with ultrafast tryptic digestion
暂无分享,去创建一个
Yi Wang | Mohammed Shameem | Huijuan Li | Yan-Hui Liu | M. Shameem | Huijuan Li | Xiaojuan Li | Yan-Hui Liu | Daisy Richardson | Xiaoyu Yang | Xiaojuan Li | Xiaoyu Yang | Yi Wang | Daisy Richardson
[1] Da Ren,et al. Structure and stability changes of human IgG1 Fc as a consequence of methionine oxidation. , 2008, Biochemistry.
[2] Catherine D. Kim,et al. Determination of the origin of the N‐terminal pyro‐glutamate variation in monoclonal antibodies using model peptides , 2007, Biotechnology and bioengineering.
[3] L. Zitvogel,et al. Cancer: Antibodies regulate antitumour immunity , 2015, Nature.
[4] I. Mellman,et al. Oncology meets immunology: the cancer-immunity cycle. , 2013, Immunity.
[5] Richard S Rogers,et al. Development of a quantitative mass spectrometry multi-attribute method for characterization, quality control testing and disposition of biologics , 2015, mAbs.
[6] M. Matsumura,et al. Isomerization of a single aspartyl residue of anti-epidermal growth factor receptor immunoglobulin gamma2 antibody highlights the role avidity plays in antibody activity. , 2008, Biochemistry.
[7] W. Xu,et al. Development of a sample preparation method for monitoring correct disulfide linkages of monoclonal antibodies by liquid chromatography-mass spectrometry. , 2016, Analytical biochemistry.
[8] Guodong Chen,et al. Structural mass spectrometry in biologics discovery: advances and future trends. , 2012, Drug discovery today.
[9] J. M. Beals,et al. In vivo deamidation characterization of monoclonal antibody by LC/MS/MS. , 2005, Analytical chemistry.
[10] Hongcheng Liu,et al. A conventional procedure to reduce Asn deamidation artifacts during trypsin peptide mapping. , 2016, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[11] A. Rathore,et al. Knowledge management in the QbD paradigm: manufacturing of biotech therapeutics. , 2015, Trends in biotechnology.
[12] Wei Xu,et al. High throughput peptide mapping method for analysis of site specific monoclonal antibody oxidation. , 2016, Journal of chromatography. A.
[13] Yang Wang,et al. Impact of methionine oxidation in human IgG1 Fc on serum half-life of monoclonal antibodies. , 2011, Molecular immunology.
[14] Roy Jefferis,et al. Glycosylation as a strategy to improve antibody-based therapeutics , 2009, Nature Reviews Drug Discovery.
[15] Thomayant Prueksaritanont,et al. Impact of methionine oxidation on the binding of human IgG1 to Fc Rn and Fc gamma receptors. , 2009, Molecular immunology.
[16] Nigel Jenkins,et al. Post-translational Modifications of Recombinant Proteins: Significance for Biopharmaceuticals , 2008, Molecular biotechnology.
[17] H. Yamaguchi,et al. Enzyme‐immobilized reactors for rapid and efficient sample preparation in MS‐based proteomic studies , 2013, Proteomics.
[18] R. Campbell,et al. Degradation of aspartic acid and asparagine residues in human growth hormone-releasing factor. , 2009, International journal of peptide and protein research.
[19] Hongcheng Liu,et al. Structural effect of deglycosylation and methionine oxidation on a recombinant monoclonal antibody. , 2008, Molecular immunology.
[20] Mohammed Shameem,et al. Separation of mAbs molecular variants by analytical hydrophobic interaction chromatography HPLC: overview and applications , 2014, mAbs.
[21] W. Ens,et al. Deamidation of -Asn-Gly- sequences during sample preparation for proteomics: Consequences for MALDI and HPLC-MALDI analysis. , 2006, Analytical chemistry.
[22] Xue Han,et al. Anti-PD-1/PD-L1 therapy of human cancer: past, present, and future. , 2015, The Journal of clinical investigation.
[23] B. Karger,et al. Comparability analysis of anti-CD20 commercial (rituximab) and RNAi-mediated fucosylated antibodies by two LC-MS approaches , 2013, mAbs.
[24] Hongcheng Liu,et al. Heterogeneity of monoclonal antibodies. , 2008, Journal of pharmaceutical sciences.
[25] B. Yan,et al. Succinimide formation at Asn 55 in the complementarity determining region of a recombinant monoclonal antibody IgG1 heavy chain. , 2009, Journal of pharmaceutical sciences.
[26] Huub Schellekens,et al. Structure-Immunogenicity Relationships of Therapeutic Proteins , 2004, Pharmaceutical Research.
[27] Gang Huang,et al. Methionine oxidation in human IgG2 Fc decreases binding affinities to protein A and FcRn , 2009, Protein science : a publication of the Protein Society.
[28] Mohammed Shameem,et al. Analysis of monoclonal antibody oxidation by simple mixed mode chromatography. , 2016, Journal of chromatography. A.
[29] A. Ambrogelly,et al. Ultrafast and high-throughput N-glycan analysis for monoclonal antibodies , 2016, mAbs.
[30] Hongcheng Liu,et al. Accurate determination of protein methionine oxidation by stable isotope labeling and LC-MS analysis. , 2013, Analytical chemistry.
[31] Ziping Wei,et al. Identification of a single tryptophan residue as critical for binding activity in a humanized monoclonal antibody against respiratory syncytial virus. , 2007, Analytical chemistry.
[32] Brian M. Murphy,et al. Stability of Protein Pharmaceuticals: An Update , 2010, Pharmaceutical Research.
[33] Ying Zhang,et al. A new tool for monoclonal antibody analysis , 2014, mAbs.
[34] Li Zang,et al. Residual metals cause variability in methionine oxidation measurements in protein pharmaceuticals using LC-UV/MS peptide mapping. , 2012, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[35] L. Weiner,et al. Mechanisms of action of therapeutic antibodies for cancer. , 2015, Molecular immunology.
[36] K. Brorson,et al. Post-translational structural modifications of immunoglobulin G and their effect on biological activity , 2014, Analytical and Bioanalytical Chemistry.
[37] Igor A Kaltashov,et al. Advances and challenges in analytical characterization of biotechnology products: mass spectrometry-based approaches to study properties and behavior of protein therapeutics. , 2012, Biotechnology advances.
[38] S. Burman,et al. Facile method of quantification for oxidized tryptophan degradants of monoclonal antibody by mixed mode ultra performance liquid chromatography. , 2012, Journal of chromatography. A.
[39] Ronald T Borchardt,et al. Aspartate isomerization in the complementarity-determining regions of two closely related monoclonal antibodies. , 2007, Biochemistry.
[40] D. Chelius,et al. Identification and characterization of oxidation and deamidation sites in monoclonal rat/mouse hybrid antibodies. , 2010, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[41] L. Presta,et al. Isomerization of an aspartic acid residue in the complementarity-determining regions of a recombinant antibody to human IgE: identification and effect on binding affinity. , 1996, Biochemistry.
[42] Alain Van Dorsselaer,et al. Characterization of therapeutic antibodies and related products. , 2013, Analytical chemistry.
[43] B. Warrack,et al. Characterization of protein therapeutics by mass spectrometry: recent developments and future directions. , 2011, Drug discovery today.